Clinical Trial Update: Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating high-dose intravenous ascorbic acid in measurable solid tumors has been withdrawn, sponsored by Situs Cancer Research Center, with co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma
• Carcinoma
• Desmoplastic Small Round Cell Tumor
• Multiple Myeloma
• Sarcoma

Drugs mentioned

• Ascorbic acid (Vitamin C)

Snippet

Sponsor: Situs Cancer Research Center | Conditions: Sarcoma, Adenocarcinoma | Phase 2 | Status: WITHDRAWN